• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

EyeGate Pharmaceuticals

edit

EyeGate Pharma is developing a proprietary platform of medicines to treat diseases of the eye using its unique, non-invasive, iontophoretic drug-delivery system called EyeGate® II. This proprietary technology platform is based on over 10-years of development at the Bascom Palmer Eye Institute at the University of Miami and has been tested extensively in both preclinical and human studies in Europe. Because of the human eye’s special anatomy, effective delivery of medicines to treat chronic disease or diseases in the mid and posterior segments of the eye is less than adequate. They believe the EyeGate® II Delivery System will offer both physicians and patients an important new alternative in advancing the treatment of eye disease.

Recent Milestones

edit

• 
  EyeGate Pharmaceuticals received $5.9M in Series D funding. (1/7/11)
  Posted 1/11/11 at 1:26am via dowjones.com
• 
  EyeGate Pharmaceuticals — Regenerative medicine firms make business of creating skin MHT's Julie Donnelly: Pharmaceuticals find drug development partners in colleges Related News Ironwood's Microbia acquired by Dutch firm [September 22, 2010] Biogen gets beat on new MS (9/22/10)
  Posted 9/23/10 at 4:06am via masshightech.com
• 
  EyeGate Pharmaceuticals received $22.6M in Series D funding. (1/8/10)
  Posted 12/21/09 at 5:24pm via finsmes.com
• 
  EyeGate Pharmaceuticals received $15M in Series C funding. (3/12/08)
  Posted 12/19/09 at 5:52am via eyegatepharma.com
• 
  EyeGate Pharmaceuticals received $10M in Series B funding. (11/2/06)
  Posted 4/23/10 at 3:17am via eyegatepharma.com
• 
  EyeGate Pharmaceuticals added Alain Maiore as Director.
  Posted 12/21/09 at 5:26pm
• 
  EyeGate Pharmaceuticals added J. Cleftie as Director.
  Posted 12/21/09 at 5:26pm
• 
  EyeGate Pharmaceuticals added Michael Mullen as Director.
  Posted 12/21/09 at 5:26pm
• 
  EyeGate Pharmaceuticals added Thomas Hancock as Director.
  Posted 12/21/09 at 5:26pm
• 
  EyeGate Pharmaceuticals added Paul Chaney as Director.
  Posted 12/21/09 at 5:26pm
• 
  EyeGate Pharmaceuticals added Morton Goldberg as Director.
  Posted 12/21/09 at 5:26pm
• 
  EyeGate Pharmaceuticals added Praveen Tyle as Director.
  Posted 12/21/09 at 5:26pm

Videos

Screenshots

edit

Above: EyeGate Pharma
Uploaded: 12/19/09

Sources

1. EYEGATE PHARMA SECURES $10M IN SERIES B VENTURE FUNDING (eyegatepharma.com) [edit]
2. EYEGATE PHARMA SECURES $15M IN SERIES C VENTURE FUNDING (eyegatepharma.com) [edit]
3. EyeGate Pharmaceuticals Raises $22.6M in Series D Financing (finsmes.com) [edit]
4. EyeGate Gets $5.9M More In Series D Funding For Dry-Eye Treatment (fis.dowjones.com) [edit]
RXi teams up with EyeGate Pharma (masshightech.com) [edit]